... Wace North America L.P. bought a new position in CymaBay Therapeutics in the 2nd quarter valued at $242,000. Ardsley Advisory Partners grew its stake in CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners now owns 50,210 ...
http://ift.tt/2BldqO6
No comments:
Post a Comment